Bacterial outer membrane lipopolysaccharide layer (LPS layer)

Bacterial outer membrane lipopolysaccharide layer Overview

The **bacterial outer membrane lipopolysaccharide layer** (LPS layer) is the defining component of the outer membrane of Gram-negative bacteria and is critical for their structure, pathogenicity, and survivability. The LPS layer is composed of large glycolipid macromolecules consisting of three parts: lipid A (the membrane anchor and main immunostimulatory moiety), a core oligosaccharide, and an O-antigen polysaccharide (which determines serotype and immune recognition)[4][5][6]. The LPS layer acts as a strong permeability barrier, preventing entry of toxic molecules and many antibiotics, and is highly resilient due to tight molecular packing and stabilization by divalent cations[2][4][7]. LPS is the primary trigger of innate immune responses in the host and is responsible for the toxicity of Gram-negative septicemia (endotoxin shock)[3][5]. While the LPS layer itself is not a single "target" in the traditional sense of a protein or receptor, it is indispensable for bacterial viability and serves as a primary target of certain antibiotics (notably polymyxins), and is the basis for numerous vaccine and diagnostic approaches[2][5][6]. Drugs may interact directly with LPS to disrupt membrane integrity, or indirectly by inhibiting its biosynthesis or transport to the outer membrane (via the LptABCDFEG protein complex)[1][2]. LPS modifications are a frequent resistance mechanism, and therapeutic strategies targeting the LPS layer face the challenge of balancing antimicrobial efficacy with avoidance of immunopathologic host responses[2][5][7].

Mechanism of Action

Disruption of outer membrane integrity (permeabilization of LPS by polymyxins) Inhibition of LPS transport or insertion (Lpt inhibitors) Neutralization of endotoxin (LPS-binding molecules)

Biological Functions

Safety Considerations

Interacting Drugs

Associated Biomarkers